The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial
Open accessAbstract
IMPORTANCE: Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE: To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS: Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES: Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS: Data from 561 participants were analyzed (alpha tocopherol = 140, memantine = 142, combination = 139, placebo = 140), with 52 excluded because of a lack of any follow-up data. Over the mean (SD) follow-up of 2.27 (1.22) years, ADCS-ADL Inventory scores declined by 3.15 units (95% CI, 0.92 to 5.39; adjusted P = .03) less in the alpha tocopherol group compared with the placebo group. In the memantine group, these scores declined 1.98 units less (95% CI, -0.24 to 4.20; adjusted P = .40) than the placebo group's decline. This change in the alpha tocopherol group translates into a delay in clinical progression of 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period. Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations," with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00235716.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“high-dose vitamin E (1000 IU twice daily was the regimen tested) may be considered based on results of 2 RCTs that supported approximately 20% lower rate of ADL decline over approximately 2 to 3 years; there were no concerning safely signals or increased mortality with high-dose vitamin E. 127,128”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Self-citationMemantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Cited by
Sorted by citations
Items 501–600 of 630
Función de las vitaminas D, E y K en condiciones especiales
Gallego, J. P. G., Marulanda, M. C. A., Yepes, F. A. J., Roldán, C. H., & Contreras, A. M. M. (2022) · Perspectivas en Nutrición Humana · doi:10.17533/udea.penh.v24n1a07 · Cited by 1
Patwardhan, B., Mutalik, G., & Tillu, G. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801282-6.00008-5 · Cited by 2
The Preventive and Treatment of the Neuro-Inflammasome in Sorokdo National HospitalPreprint
Lee, J., Lee, C. J., Park, J., Lee, S. J., Choi, S.-H., & Oh, S.-S. (2021) · Research Square · doi:10.21203/rs.3.rs-243831/v2 · Cited by 1
Kann der Verlauf gemildert werden?
Weih, M. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-014-0802-x
Update in Outpatient General Internal Medicine: Practice-changing Evidence Published in 2014
Sundsted, K. K., Wieland, M. L., Szostek, J. H., Post, J. A., & Mauck, K. F. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.04.033
Role of micronutrients for healthy ageing – moving towards collaborative personalized nutrition
Eggersdorfer, M. L. (2014) · Bijblijven · doi:10.1007/s12414-014-0047-0
Rikkert, M. G. M. O., Knijff, S., Perry, M., & Claassen, J. A. H. R. (2014) · Bijblijven · doi:10.1007/s12414-014-0045-2
Staff get new guidance on physical restraint
Learner, S., & Nazarko, L. (2014) · Nursing and Residential Care · doi:10.12968/nrec.2014.16.2.68
REDOX PROCESSES AND OXIDATIVE STRESS IN CELL AND TISSUE DAMAGE
Selenius, L. A. (2015) · Figshare
Vitamin E zögert die Progression nur ganz leicht hinaus
Hermann, D. M. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-014-0852-0
Alzheimer’s Disease Management: Current Therapy and Recent Drug Development
Abbasi, M., & Alam, M. R. (2016) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2016/24771
Vitamin E Outpaces Memantine in Mild-to-Moderate Alzheimer Disease
Matthews, B. R. (2014) · Journal watch · doi:10.1056/nejm-jw.na33250
Haynes, N., Seifan, A., & Isaacson, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-18377-0_2
Vitamin E Supplementation for Mild-to-Moderate Alzheimer Disease
Brett, A. S. (2014) · Journal watch · doi:10.1056/nejm-jw.na33523
Featured Article Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Siemers, E., Sundell, K. L., Carlson, C. D., Case, M. G., Sethuraman, G., Liu‐Seifert, H., Dowsett, S. A., Pontecorvo, M. J., Dean, R. A., & Demattos, R. B. (2016)
Efficacy of three nonpharmacological interventions for Alzheimer's disease
Artiles, A. T. (2016) · OpenBU (Boston University)
Evaluation and management of dementia
Collins, L., Rovner, B. W., & Collins-Fletcher, K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.010
Budson, A. E., & Solomon, P. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28661-9.00018-4
The Impact of Decline on Everyday Life in Alzheimer's Disease
Park, L. Q., & Busson, B. (2015) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-4666-8478-2.ch014
Therapeutic Strategies Harnessing Oxidative Stress to Treat Stroke
Hadley, G., Neuhaus, A. A., & Buchan, A. M. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-7693-2_7
The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease
Chopra, N. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c28019
Approaches to Ensuring Food and Nutrition Security in the Elderly
Mohajeri, M. H., Weber, P., & Eggersdorfer, M. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-55942-1_28
Potential Treatments for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00008-2 · Cited by 1
Kubo, A. (2017) · Health Evaluation and Promotion · doi:10.7143/jhep.44.642
Nutritional Supplementation: A Case for L-Carnitine
Virji, A. (2018) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1429515
Current management tactics for patients with dementia
Medvedeva, A. V., Kosivtsova, O. V., & Алексеевич, М. К. (2018) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2018-2-102-108
Public Health Approaches to Alzheimer’s Disease
Blank, R. H. (2018) · Springer eBooks · doi:10.1007/978-981-13-0656-3_5
Vitamin E for Alzheimer disease: The answer is not so E-asy
Ellis, K., Rollins, C. J., & Krinsky, D. L. (2017) · Pharmacy Today · doi:10.1016/j.ptdy.2017.05.006
Bohlken, J., & Kostev, K. (2018) · Monitor Versorgungsforschung · doi:10.24945/mvf.06.18.1866-0533.2110
ANTIOXIDANT SUPPLEMENTS IN ALZHEIMER’S DEMENTIA AND MILD COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW
Pegg, E. (2016) · Journal of Aging Research and Lifestyle · doi:10.14283/jarcp.2016.121
Nutritional and Botanical Approaches for Cognitive Health—Part 1
Lucius, K. (2019) · Alternative and Complementary Therapies · doi:10.1089/act.2019.29230.klu
Pharmacological Interventions in Older Adults
Patel, J. J., Smith, D. W., Heafner, J., Christopher, N. G., & Grossberg, G. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-10814-4_9
Pharmacological Agents to Treat Severe Neuropsychiatric Symptoms in Major Neurocognitive Disorders
Mischel, N., Rakesh, G., Gupta, S., Muzyk, A. J., & Masand, P. S. (2020) · Annals of Clinical Psychiatry · doi:10.1177/104012372003200212
Modernized Divination into Ferroptosis
Jain, R. R. (2020) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2020.30622
Slozhenkina, M. I., Komarova, Z. B., Voronina, T. V., Валерьевна, Р. А., & Friesen, D. V. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/548/8/082041
A systematic review of interventions that reduce family caregiving time
Baker, Z. G., Jutkowitz, E., & Gaugler, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-813898-4.00004-x
Dementia Management Act and Death Toll by Dementia DrugPreprint
Lee, J.-H. (2021) · Research Square · doi:10.21203/rs.3.rs-384861/v2
Aging, dietary patterns, and cognition
Abbatecola, A. M., & Marfella, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00045-7
Degenerative Diseases of the CNS
Capizzano, A. A., Moritani, T., & Capizzano, J. N. (2021) · Springer eBooks · doi:10.1007/978-3-030-62120-9_14
Issues in Long-Term Care Psychiatry
Desai, A. K., & Grossberg, G. T. (2017)
Alzheimer's Disease: Knowledge of Early Detection, Risk Factors, and Treatment
Smith, A. H., & Spadino, K. S. (2016)
Nährstoffversorgung in Deutschland und Auswirkung auf die Gesundheit
Eggersdorfer, M. L., & Schettler, T. (2021) · Ernährung & Medizin · doi:10.1055/a-1593-8153
Young, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc242.pub2
Deardorff, W. J., & Grossberg, G. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-74604-3_9
Leray, C. (2014) · CRC Press eBooks · doi:10.1201/b17656-5
Clinical Applications of Aspirin
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch4
Cognitive decline and Alzheimer’s disease
Leray, C. (2017) · CRC Press eBooks · doi:10.1201/9781315268828-5
Larner, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6371-8_9
Prevention of Cognitive Decline
Lugavere, M., Seifan, A., & Isaacson, R. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_14
Vitamin E and Cognitive Functions: What Is the Interplay?
Azimi, M., & Atiq, M. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_2
Current Treatments for Alzheimer’s Disease
Sano, M., & Neugroschil, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0057
Dementia Management Act and Death Toll by Dementia DrugPreprint
Lee, J. (2021) · Research Square · doi:10.21203/rs.3.rs-384861/v1
The Preventive and Treatment of the Neuro-Inflammasome in Sorokdo National HospitalPreprint
Lee, J., Lee, C. J., Park, J., Lee, S. J., & Choi, S.-H. (2021) · Research Square · doi:10.21203/rs.3.rs-243831/v3
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804538-1.00036-5
Dementia Management Act and Death Toll by Dementia DrugPreprint
Lee, J. (2021) · Research Square · doi:10.21203/rs.3.rs-384861/v3
The Preventive and Treatment of the Neuroinflammasome in Sorokdo National HospitalPreprint
Lee, J., Lee, C. J., Lee, S. J., Choi, S.-H., Oh, S.-S., & Park, J. (2021) · Research Square · doi:10.21203/rs.3.rs-243831/v4
Muayqil, T. A., & Camicioli, R. M. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000359967
Verdonschot, T., & Kat, M. G. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1247-4_10
The Impact of Decline on Everyday Life in Alzheimer's Disease
Park, L. Q., & Busson, B. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-7122-3.ch001
Verdonschot, T., & Kat, M. G. (2019) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2374-6_11
Matthews, B. R. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.009
100 Jahre Vitamin-E-Forschung: Status, Ausblick und zukünftige Entwicklungen
Wallert, M., & Eggersdorfer, M. L. (2022) · Ernährung & Medizin · doi:10.1055/a-1743-6605
Die Vitamin-E-Versorgung in Deutschland: ausreichend, aber nicht optimal
Eggersdorfer, M. L., & Schettler, T. (2022) · Ernährung & Medizin · doi:10.1055/a-1856-2837
Neuropharmacology in Alzheimer and Huntington Disease
Gupta, B., & Rohatgi, K. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010015
Az Alzheimer-kór mint világméretű népbetegség
Antal, M., Szabolcs, P., & Eggersdorfer, M. L. (2018) · Egeszsegtudomany · doi:10.29179/egtud.2018.3-4/58-81
Advances in Comprehensive Treatment of the Alzheimer's Disease
Jiang, W. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5793
Nutraceuticals and gutbiota-brain axis
Jarouliya, U., & Jain, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00022-0
Current Status of Antioxidants in clinical practices - A Review
Bhure, A. S., Joshi, A., Khanavkar, R., & Agashe, A. (2023) · International Journal of Allied Medical Sciences and Clinical Research · doi:10.61096/ijamscr.v11.iss4.2023.487-495
Limitations and Future Directions for 4-Hexylresorcinol Applications
Kim, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-0637-2_9
Dietary supplements may boost memory, but more evidence is required
Kang, C. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01070-z
Advancing age, nutraceuticals, and neuroprotection
Woźniak, L. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00001-2
Neuropsychiatric Symptoms (NPS) and Neurocognitive Disorders
Bhojani, Z., Ghodasara, S., Patience, J., Ross, E., Hitching, R., Fenn, H. H., & Burhan, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_5
Trentman, C., Louissaint, L. G., & Enaohwo, O. (2024) · Springer eBooks · doi:10.1007/978-3-031-66885-2_1
Nutraceuticals in the prevention and treatment of Alzheimer's disease
Mishra, D. K., Mishra, S. K., Asthana, A., Audah, K. A., Singh, M. P., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00008-2
Prajapati, J. L., Dhurandhar, Y., Singh, A. K., Gupta, D. K., Baghel, V. S., Kushwaha, U., & Namdeo, K. P. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2489558
Wu, Y., Zhou, H., Cai, Y., Du, W., Li, C., & Sun, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1597724
Vitamin E as a Therapeutic Agent for NAFLD: A Systematic Review of Randomized Controlled Trials
Liu, C., Bai, Z., & Cheng, J. (2025) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20251304.12
Nutraceuticals intervention in Alzheimer's disease: From farm to pharma
Chaithra, P. M., Rakshith, B. S., Logesh, S., Basalingappa, K. M., Gopenath, T. S., Chang, H., Perry, G. L., & Singh, S. K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251385216
Vitamins and Their Role in Alzheimer’s Disease
Joshi, D. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_19
Alzheimer’s Biochemistry and Therapeutic Prospects of Functional Foods-based Strategies
Akanbi, C. A., Akanji, M. A., & Adeyemı, O. S. (2025) · The Open Biochemistry Journal · doi:10.2174/011874091x416492251129102634
Kat, M. G., & Bergsma, G. F. W. (2025) · doi:10.1007/978-90-368-3192-5_11
TARGETED DELIVERY OF ANTICANCER AGENTS TO CANCER
Lu, J. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Rodriguez‐Porcel, F. E., Wyman‐Chick, K. A., Ruiz, C. A., Toledo, J. B., Ferreira, D., Urwyler, P., Weil, R. S., Kane, J., Pilotto, A., Rongve, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19689331
Rodriguez‐Porcel, F. E., Wyman‐Chick, K. A., Ruiz, C. A., Toledo, J. B., Ferreira, D., Urwyler, P., Weil, R. S., Kane, J., Pilotto, A., Rongve, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19689334
Rodriguez‐Porcel, F. E., Wyman‐Chick, K. A., Ruiz, C. A., Toledo, J. B., Ferreira, D., Urwyler, P., Weil, R. S., Kane, J., Pilotto, A., Rongve, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19689340
Rodriguez‐Porcel, F. E., Wyman‐Chick, K. A., Ruiz, C. A., Toledo, J. B., Ferreira, D., Urwyler, P., Weil, R. S., Kane, J., Pilotto, A., Rongve, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19689343
Metadata
- Authors
- Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., Prieto, S., Chen, P., Loreck, D. J., Trapp, G., Bakshi, R. S., Mintzer, J. E., Heidebrink, J. L., Vidal-Cardona, A., Arroyo, L. M., Cruz, A. R., Zachariah, S., Kowall, N. W., Chopra, M. P., Craft, S., Thielke, S., Turvey, C. L., Woodman, C., Monnell, K. A., Gordon, K., Tomaska, J., Segal, Y., Peduzzi, P. N., & Guarino, P. D.
- Affiliations
- Minneapolis VA Health Care System (US)
- James J. Peters VA Medical Center (US)
- William S. Middleton Memorial Veterans Hospital (US)
- Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico
- Louis Stokes Cleveland VA Medical Center (US)
- Washington DC VA Medical Center (US)
- University of Pennsylvania (US)
- Miami VA Healthcare System (US)
- VA Maryland Health Care System (US)
- VA North Texas Health Care System (US)
- Medical University of South Carolina (US)
- VA Ann Arbor Healthcare System (US)
- VA Caribbean Healthcare System, San Juan, Puerto Rico
- VA Caribbean Healthcare System (PR)
- Bay Pines VA Healthcare System (US)
- VA Boston Healthcare System (US)
- University of Washington (US)
- University of Iowa (US)
- W. G. (Bill) Hefner VA Medical Center (US)
- Yale University (US)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-01-01
- Volume
- 311
- Issue
- 1
- Pages
- 33
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4109898
- OpenAlex
- W2128047032
- Cited by
- 628
- References
- 40
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 36 · 2023: 54 · 2022: 56 · 2021: 53 · 2020: 47 · 2019: 47 · 2018: 61 · 2017: 48 · 2016: 50 · 2015: 55 · 2014: 44
- FWCI
- 35.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P50AG005138, P30AG013846, P50AG005136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, vitamin E, alpha-tocopherol, memantine, functional decline, activities of daily living, acetylcholinesterase inhibitors, disease progression, caregiver burden, neuropsychiatric symptoms, adverse events, infections and infestations, combination therapy, veterans, older adults, cognitive decline, mortality, quality of life, cost-effectiveness
- MeSH terms
- Activities of Daily Living, Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Cholinesterase Inhibitors, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memantine, Middle Aged, Severity of Illness Index, Vitamin E, Dopamine Agents, Treatment Outcome, Caregivers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
